Northwest Biotherapeutics Board Veteran Jasinowski Retires
Company Announcements

Northwest Biotherapeutics Board Veteran Jasinowski Retires

Northwest Biotherapeutics (NWBO) has issued an update.

After over ten years of dedicated service, Mr. Jerry Jasinowski has retired from the Board of Directors at Northwest Biotherapeutics, Inc. as of March 8, 2024. At 85 years old, his retirement is attributed to health reasons and bears no connection to any disputes over the company’s operations, policies, or practices. Northwest Biotherapeutics extends its gratitude to Mr. Jasinowski for his longstanding commitment to the Board.

See more insights into NWBO stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskNorthwest Biotherapeutics Addresses Market Rumor Concerns
TheFlyNorthwest Biotherapeutics announces exclusive license from Roswell Park
TipRanks Auto-Generated NewsdeskNorthwest Biotherapeutics Appoints Pat Sarma as Class II Director
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App